We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
-3.95%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$1.92B
AUM Growth
-$267M
Cap. Flow
-$176M
Cap. Flow %
-9.2%
Top 10 Hldgs %
36.15%
Holding
320
New
22
Increased
113
Reduced
115
Closed
20

Sector Composition

Rank Sector Weight
1 Technology 16.52%
2 Healthcare 10%
3 Financials 6.86%
4 Industrials 5.86%
5 Consumer Discretionary 4.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ILCV icon
251
iShares Morningstar Value ETF
ILCV
$1.35B
$265K 0.01%
3,858
CAT icon
252
Caterpillar
CAT
$404B
$262K 0.01%
1,174
MU icon
253
Micron Technology
MU
$1.01T
$261K 0.01%
3,356
+32
+1% +$2.73K
IVW icon
254
iShares S&P 500 Growth ETF
IVW
$77.3B
$260K 0.01%
3,406
+531
+18% +$39.9K
HDSN
255
Hudson Technologies
HDSN
$266M
$256K 0.01%
41,163
+7,741
+23% +$34.3K
SCHD icon
256
Schwab US Dividend Equity ETF
SCHD
$105B
$254K 0.01%
9,660
VB icon
257
Vanguard Morningstar Small-Cap ETF
VB
$82.3B
$251K 0.01%
1,182
-78
-6% -$16.4K
INVA icon
258
Innoviva
INVA
$1.54B
$250K 0.01%
12,925
+1,205
+10% +$21.5K
LNG icon
259
Cheniere Energy
LNG
$53.9B
$250K 0.01%
+1,800
New +$219K
EZU icon
260
iShare MSCI Eurozone ETF
EZU
$9.85B
$249K 0.01%
5,747
+14
+0.2% +$637
ALBO
261
DELISTED
Albireo Pharma Inc
ALBO
$244K 0.01%
+8,191
New +$240K
AMT icon
262
American Tower
AMT
$81.7B
$240K 0.01%
957
-19
-2% -$4.64K
LUMN icon
263
Lumen
LUMN
$6.91B
$239K 0.01%
21,184
SSO icon
264
ProShares Ultra S&P500
SSO
$8.32B
$238K 0.01%
7,244
-988
-12% -$31.6K
VRTX icon
265
Vertex Pharmaceuticals
VRTX
$121B
$238K 0.01%
+911
New +$216K
INTU icon
266
Intuit
INTU
$88.5B
$237K 0.01%
494
-44
-8% -$22.5K
ELV icon
267
Elevance Health
ELV
$82B
$236K 0.01%
480
NOC icon
268
Northrop Grumman
NOC
$78.4B
$235K 0.01%
525
IWS icon
269
iShares Russell Mid-Cap Value ETF
IWS
$16B
$232K 0.01%
1,940
-146
-7% -$17.2K
GIS icon
270
General Mills
GIS
$19.3B
$230K 0.01%
3,398
-91
-3% -$6.1K
IWR icon
271
iShares Russell Mid-Cap ETF
IWR
$57.3B
$227K 0.01%
2,912
-640
-18% -$49.3K
VTV icon
272
Vanguard Morningstar Value ETF
VTV
$191B
$223K 0.01%
1,512
+14
+0.9% +$2.04K
DD icon
273
DuPont de Nemours
DD
$19.3B
$222K 0.01%
2,399
-24
-1% -$2.34K
EXC icon
274
Exelon
EXC
$47.2B
$222K 0.01%
4,667
-1,652
-26% -$70K
PSA icon
275
Public Storage
PSA
$61B
$222K 0.01%
570
-52
-8% -$18.9K

Similar funds

Grimes & Company's Q1 2022 Portfolio in Review

As of Q1 2022, Grimes & Company held 320 positions worth $1.92B, down 12% from $2.18B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Grimes & Company withdrew a net $176M in Q1 2022, closing 20 positions and reducing 115 holdings. Its most notable exit was Xilinx Inc, an estimated $19M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Grimes & Company opened a new position in Advanced Micro Devices worth $16.6M.

  • Grimes & Company's largest Q1 2022 buy was Advanced Micro Devices: 151,681 shares worth $16.6M.
  • Grimes & Company added most to State Street Health Care Select Sector SPDR ETF in Q1 2022, an estimated $19.5M increase.
  • Grimes & Company's biggest Q1 2022 reduction was State Street Blackstone Senior Loan ETF, cutting an estimated $128M.
  • Grimes & Company fully exited Xilinx Inc in Q1 2022, selling an estimated $19M.
  • Grimes & Company's ten largest holdings make up 36% of its $1.92B portfolio in Q1 2022.
  • Grimes & Company opened 22 new positions and closed 20 in Q1 2022.
  • Grimes & Company's portfolio value fell 12% quarter-over-quarter to $1.92B.

Based on Grimes & Company's 13F filing for Q1 2022, filed 6 May 2022.